Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Amicogen Logo
Amicogen Growth Score
35
CB Rank
2751098
Heat Score
6
Amicogen is a biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Jinju, Kyongsang-namdo, South Korea51-100 amicogen.com/
Biotechnology
Health Care
Nutrition
Pharmaceutical
Overview

Amicogen
Total Funding
obfuscation
Growth Score
35
Heat Score
6

Total Funding
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score35
-2 pts
in past quarter
Heat Score 6
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Amicogen

CB Rank
2751098
Amicogen is a biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Jinju, Kyongsang-namdo, South Korea51-100 amicogen.com/
Biotechnology
Health Care
Nutrition
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Amicogen, Inc.
Operating Status Active
Stock Symbol  KOSDAQ:092040
Company Type For Profit
Founders  Shin Chul
About the Company
Amicogen develops bioproducts and health functional food ingredients. Their products include endo-lac, ginseng extraction powder, cauliflower mushrooms, chitosan oligosaccharides, chitoslim, keyclean, and more.
Phone Number 055-759-6161
Contact Email amicogen@amicogen.com
Predictions & Insights

Products & Services

Specialty Enzymes
Industrial and pharmaceutical enzymes developed for various applications in multiple fields.
Bio-based New Materials
Enzyme-based bio-materials developed using scientific evidence and indicators for various applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Amicogen Logo
Post-IPO Equity - Amicogen
2
obfuscation
— Post-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Aug 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 20, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,031
23.33%
 in past month

Active Website Tech Count

6Amicogen is actively using 6 technologies for its website, according to BuiltWith. These include SSL by Default, DNSSEC, and  LetsEncrypt.

Total IP

22The intellectual property of Amicogen includes 12 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Amicogen has registered 10 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Amicogen's headquarters? Amicogen is located in Jinju, Kyongsang-namdo, South Korea.Who invested in Amicogen? Amicogen has 4 investors including Hyundai Venture Investment Corporation and  Company K Partners.When was the last funding round for Amicogen? Amicogen closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Amicogen's competitors? Alternatives and possible competitors to Amicogen may include Basecamp Research, Foghorn Therapeutics, and  Biotoloomics.How much funding has Amicogen raised to date? Amicogen has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|